Recommended Alerts

Sign Up For Alerts

Developments in Drug Pricing and Price Reporting as the Congressional Recess Approaches (August 2021)

As the August congressional recess approaches, there have been several developments in the drug pricing/price reporting space. All branches of government have worked to tackle drug pricing in recent months, and by late August we may have a much stronger sense of the direction the Biden Administration intends to take to address drug pricing through administrative action.

Read More

Increased Scrutiny of the Pharmaceutical Industry and its Relationship with Academic Medical Centers and Health Care Providers

Practices: Health Care

Printer-Friendly Version

Cookie Settings